STERIS plc (NYSE:STE) Stake Lessened by Penobscot Investment Management Company Inc.

Penobscot Investment Management Company Inc. decreased its position in shares of STERIS plc (NYSE:STE) by 33.5% during the 4th quarter, Holdings Channel.com reports. The firm owned 6,657 shares of the medical equipment provider’s stock after selling 3,350 shares during the quarter. Penobscot Investment Management Company Inc.’s holdings in STERIS were worth $1,368,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Magnolia Capital Advisors LLC raised its stake in shares of STERIS by 1.9% in the 4th quarter. Magnolia Capital Advisors LLC now owns 2,534 shares of the medical equipment provider’s stock worth $521,000 after buying an additional 48 shares in the last quarter. SkyView Investment Advisors LLC raised its position in STERIS by 1.6% in the third quarter. SkyView Investment Advisors LLC now owns 3,153 shares of the medical equipment provider’s stock worth $765,000 after acquiring an additional 51 shares in the last quarter. Park Edge Advisors LLC raised its position in STERIS by 1.1% in the fourth quarter. Park Edge Advisors LLC now owns 4,662 shares of the medical equipment provider’s stock worth $958,000 after acquiring an additional 51 shares in the last quarter. Citizens Financial Group Inc. RI lifted its holdings in STERIS by 5.9% in the 4th quarter. Citizens Financial Group Inc. RI now owns 975 shares of the medical equipment provider’s stock valued at $201,000 after acquiring an additional 54 shares during the last quarter. Finally, Opal Wealth Advisors LLC boosted its position in shares of STERIS by 5.7% during the 4th quarter. Opal Wealth Advisors LLC now owns 1,118 shares of the medical equipment provider’s stock valued at $230,000 after purchasing an additional 60 shares in the last quarter. 94.69% of the stock is currently owned by institutional investors and hedge funds.

STERIS Stock Up 0.6 %

NYSE:STE opened at $223.03 on Thursday. STERIS plc has a 1-year low of $197.82 and a 1-year high of $248.24. The firm has a market capitalization of $21.91 billion, a price-to-earnings ratio of 47.35 and a beta of 0.92. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. The business’s fifty day moving average price is $221.95 and its 200 day moving average price is $221.61.

STERIS (NYSE:STE) last posted its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. On average, sell-side analysts forecast that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 21st. Stockholders of record on Thursday, February 20th were paid a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.02%. The ex-dividend date of this dividend was Thursday, February 20th. STERIS’s dividend payout ratio (DPR) is presently 48.41%.

Analyst Upgrades and Downgrades

Several analysts recently commented on STE shares. Stephens reissued an “overweight” rating and set a $240.00 target price on shares of STERIS in a research note on Thursday, February 6th. Piper Sandler increased their price objective on STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. Finally, JMP Securities reissued a “market outperform” rating and set a $265.00 price objective on shares of STERIS in a research note on Thursday, February 6th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.